NL-OMON20323尚未招募不适用
Serum Amyloid A as a prognostic marker for disease severity and mortality in COVID-19
Board of Directors Franciscus Gasthuis & Vlietland0 个研究点目标入组 350 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 350
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •18 jaar or older;
- •hospitalised for (suspicion of) COVID-19;
- •written informed consent for those subjects admitted to the non-ICU clinical COVID-19 ward.
排除标准
- •Subjects undergoing experimental interventions will be excluded.
研究者
相似试验
已完成
不适用
Serum Amyloid A as a prognostic marker for disease severity and mortality in COVID-19NL-OMON51218Franciscus Gasthuis & Vlietland150
已完成
不适用
The Diagnostic and Prognostic Role of SAA in Intrathoracic SarcoidosisSarcoidosis, PulmonaryNCT05811962University Medical Centre Ljubljana135
已完成
4 期
The clinical prognostic value of amyloid imaging with [18F]AV-45 in a subjects with subjective complaintsdementia of the Alzheimer type1002930510012272Alzheimer's DiseaseNL-OMON47767Vrije Universiteit Medisch Centrum280
招募中
2 期
Plasma biomarker reflecting cerebral amyloid deposition: a multicenter study for the clinical applicatioAlzheimer's disease Other Dementia Mild cognitive impairment (MCI) Healthy volunteerJPRN-UMIN000023976ational Center for Geriatrics and Gerontology400
Unknown
不适用
Maternal Serum Amyloid A Levels in Pregnancies Complicated With Preterm Labour.Preterm LaborNCT03205020mona nematallah58